xiaolong zhao: Clinical Trials

4 trials sponsored by xiaolong zhao, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown, 1 completed. 2 Not applicable, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable2Unknown 2
Phase 41Unknown 1

Follow xiaolong zhao: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intervention Effect of Canagliflozin on Prediabetes in Patients With HIV.
Canagliflozin, Placebo - PreDiabetes, Hiv
Not applicableUnknownxiaolong zhao2182022-01-012022-03-08
Insulin Dose Calculation Software in Insulin Therapy
Wechat program - Time in Range, Artificial Intelligence
Not applicableUnknownxiaolong zhao1822021-10-012022-10-24
Effect on Beta Cell Function and Glycaemic Control After Insulin and Exenatide Sequential Therapy
Exenatide, Metformin - Type 2 Diabetes
Phase 4Unknownxiaolong zhao1002014-02-012014-05-02
Differential Diagnosis of STA-PSV in Thyrotoxicosis
Thyrotoxicosis, Peak Systolic Velocity of Superior Thyroid Artery
Completedxiaolong zhao1692010-06-012014-05-05

Conditions studied

Acquired Immunodeficiency Syndrome (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Graves Disease (1)  ·  Prediabetic State (1)  ·  Thyroiditis (1)  ·  Thyrotoxicosis (1)

Interventions

Canagliflozin (1)  ·  Exenatide (1)  ·  Metformin (1)

Countries

China (4)

Results publications

PMID 23166817, PMID 41697460